InvestorsHub Logo
Followers 116
Posts 1878
Boards Moderated 0
Alias Born 11/22/2017

Re: flipper44 post# 278578

Sunday, 04/19/2020 11:22:35 AM

Sunday, April 19, 2020 11:22:35 AM

Post# of 704559

In Europe, more preparations were made than many people realize, imho, and more money was recently injected.



Flipper44,

That’s correct IMO.

Last month Dr Mike Scott, COO, Advent Bioservices, was one of the experts discussing the ATMP manufacturing landscape in the UK and the current challenges.
The title of the ATN EVENT is obvious – "ATMP Manufacturing: Making the UK the World Leader".
https://www.medcityhq.com/news-and-events/

17:10 Session 1: The ATMP manufacturing landscape in the UK and the current challenges
17:10 – Keynote – Ian McCubbin, OBE, Chair RoslinCT and Manufacturing advisory group Innovate
17:25 – Panel Discussion
Prof Uta Griesenbach, Imperial College London
Matthew Durdy, CBO, Cell and Gene Therapy Catapult
Dr James Miskin, CTO, Oxford Biomedica
Prof Farzin Farzaneh, King’s College London
Peter Coleman, CEO, Cobra Biologics
Dr Mike Scott, COO, Advent Bioservices



Picture:
The man in the middle is Mike Scott.
https://twitter.com/UCLTRO/status/1238161125948166145/photo/1

And a comment:
Kamar Johnson@johnson_kamar

Great session with interesting takes on #ATMP manufacture.




Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News